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The expression of caveolin-1 and -2 in the retina was
examined; Western blot analysis showed that both were
present. Immunohistochemistry indicated that caveolin-1
was expressed in the majority of retinal layers, including
the ganglion cell layer, inner plexiform layer, outer
plexiform layer, and in the vascular endothelial cells of the
retina. Caveolin-2 was primarily immunostained in the
vessels, but in a few other elements as well. This is the first
demonstration of caveolin differential expression in the
retina of rats, and suggests that caveolin plays an
important role in signal transduction in glial cells and
neuronal cells.
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Introduction
Caveolin has been shown to be involved in many signal
transduction mechanisms, including phosphorylation by
protein kinases, and signaling by G-proteins [8]. Caveolin is
also known as a cholesterol-binding membrane protein
involved in cellular cholesterol transport and homeostasis
[3,5]. In addition, caveolin seems to be related to caveolae
formation, where it plays an important role in the specific
localization of proteins and other components involved in
signal transduction [4]. Three isotypes of the protein have
been identified: caveolin-1, -2, and -3; both caveolin-1 and
caveolin-2 are abundantly expressed in a variety of tissues
including brain [6], and heart [15]. Because signal transduction
and lipid metabolism are central to the function of nervous
tissues, recent studies have focused on the expression of
caveolins in the nervous system. Normal brain tissue has
been examined [7], as well as brain from Alzheimer’s
disease patients [5], as well as the spinal cord tissue from
experimental autoimmune encephalomyelitis [12].
The retina is a remote organ of the central nervous system,
and consists of various cell types, including neuronal cells
and glial cells [13]. Caveolin-1 plays an important role in the
normal physiology of the retina [1], and in pathological
conditions including a prion disease model [9]. However,
little is known about the normal expression of caveolin in
the retina of the rat. The aim of the present study was to
examine and to localize the expression of each of the
caveolins in the rat retina.
Materials and Methods
Animals
Male Sprague Dawley rats (200-250 g) were obtained
from Chungang Animal Laboratory (Korea). The aniamals
were housed in cages in a standard barrier facility, and
maintained on a 12-h light: 12-h dark cycle at 23
oC. The
research was conducted in accordance with the internationally
accepted principles for laboratory animal use and care as
found in the NIH guidelines (USA).
Tissue sampling
To collect samples, six rats were deeply anesthetized with
chloral hydrate (Fluka, Switzerland) (375 mg/kg body
weight, intra-peritoneal injection), and the eyes were
enucleated. The anterior segments of both eyes were
removed from each rat, and the retina of one eye was
separated for Western blot analysis. The eyecup of the
second eye was fixed by immersion in 10% formalin in 0.1
M phosphate buffered saline (PBS), pH 7.4, for 24 h before
paraffin embedding.
Antibodies
The antibodies used in this study included mouse
monoclonal anti-caveolin-1 (IgG1, clone 2297), and anti-
caveolin-2 (IgG1, clone 65), all obtained from BD
Biosciences (USA). Mouse monoclonal anti-beta-actin was
obtained from Sigma (USA). The specificity of each
monoclonal antibody to caveolin-1, or -2 has been well
characterized; no cross-reactivity between antibodies has
been detected [10,11,14].
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Western blot analysis
The retinas and hearts from rats were separately
homogenized in lysis buffer (40 mM Tris, 120 mM NaCl,
0.1% Nonidet 40, 2 mM Na3VO4, 1 mM PMSF, 10 µg/ml
aprotinin, 10 µg/ml leupeptin) and then centrifuged to
remove any insoluble material. Samples were mixed with
loading buffer and electrophoresed under denaturing
conditions by 12% SDS-polyacrylamide gel electrophoresis.
The proteins were then electroblotted in transfer buffer to
nitrocellulose membranes (Schleicher & Schuell, USA) for
2 h at 100 V. Residual binding sites on the membranes were
blocked by incubation with 5% non-fat milk in Tris-buffered
saline (TBS; 10 mM Tris-HCl, pH 7.4, and 150 mM NaCl)
for 1 h. Membranes were then incubated for 1 h with mouse
antibody against either caveolin-1, or caveolin-2. The blots
were washed three times in TBS containing 0.1% Tween-
20, and then probed with horseradish peroxidase-conjugated
anti-mouse IgG (Vector, USA) for 1 h. The blots were
developed using enhanced chemiluminescence reagents
(Amersham, USA), according to the manufacturer’s instructions.
Heart tissue was used as a positive control for caveolin-1
and -2 [15]. After imaging, the membranes were stripped
and reprobed using monoclonal anti-beta-actin antibody as
the primary antibody (Sigma, USA).
Immunohistochemistry
Paraffin sections (5 µm) of rat eyecups were deparaffinized
and pretreated with citrate buffer (0.01 M, pH 6.0) in a
microwave oven for 2 min. After hydration, the sections
were treated with 0.3% hydrogen peroxide in distilled water
for 20 min to block endogenous peroxidase activity. After
three washes in PBS, the sections were exposed to 10%
normal horse serum and then incubated for overnight at 4
oC
with mouse monoclonal antibodies against either caveolin-
1, or caveolin-2 (all at 1 : 200 dilution). After three further
washes, the sections were incubated with biotinylated
second antibody, followed by formation of avidin-biotin
peroxidase complexes using the Elite kit (Vector, USA). The
peroxidase reaction was developed with a diaminobenzidine
substrate (Vector, USA). Before mounting, the sections were
counterstained with hematoxylin. In the negative control, no
immunostaining was seen in sections where primary
antiserum was omitted (Fig. 2B).
Results
Western blot analysis of caveolin-1 and -2 in rat retina
Western blotting revealed the presence of caveolin-1 (Fig.
1A), and caveolin-2 (Fig. 1B) in the retinas of adult rats.
Caveolin-1 immunoreactivity was detected in a band with
an approximate molecular weight of 22 kDa. The same band
was also observed in rat heart extracts, and observed to run
in parallel, confirming the specificity of the antibody for
caveolin-1 (Fig. 1A). For caveolin-2, there were two bands
typically detected in retinas, a major band of approximately
20 kDa, and a minor band of approximately 18 kDa (Fig.
1B).
Immunohistochemical localization of caveolin-1 and -2
in rat retina
Expression of caveolin-1 was detected in the internal
limiting layer and optic nerve fiber layer (Fig. 2A). In the
ganglion cell layer, caveolin-1 was weakly localized to the
cell membranes and nuclei of ganglion cells (Fig. 2C).
Caveolin-1 was diffusely expressed in the plexiform layer,
which contained bipolar axons, ganglion cell dendrites, and
amacrine cell processes (Fig. 2C). In the inner nuclear layer,
caveolin-1 immunoreactivity was weakly detected in the
cellular membranes and nuclei of amacrine cells, and
bipolar cells (Fig. 2D). Caveolin-1 staining was diffuse in
the outer plexiform layer, which contains axonal ends of
photoreceptor cells, dendritic processes of the bipolar cells
and processes of the horizontal cells (Fig. 2E). In the outer
nuclear layer, weak caveolin-1 immunoreactivity was seen
in photoreceptor cells, and in the external limiting
membrane, but little was detected in inner segments of rods
and cones (Fig. 2F).
The immunostaining pattern of caveolin-2 in the retina
was largely the same as that of caveolin-1, but was much
weaker (Fig. 3A). Caveolin-2 immunostaining was however,
intensely detected in vessels (Fig. 3A). Also, caveolin-2 was
Fig. 1. Identification of caveolin-1 and -2 in the rat retina. Protei n
(40 µg) from heart and retina homogenates of adult rats were
separated by SDS-PAGE (12%), and then immunoblotted wit h
caveolin-1 (A) and caveolin-2 (B) antibodies, respectively. Beta-
actin was used as a control. Molecular weight markers are
indicated on the right. Blots are representative of data from  a
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diffusely stained in inner plexiform layer (Fig. 3B), inner
nuclear layer (Fig. 3C), and outer plexiform layer (Fig. 3D).
Caveolin-2 was immunostained in the processes of glial
cells (Fig. 3A, arrowhead) and of identical Muller cells (Fig.
3C, arrow). Caveolin-2 immunoreactivity was very limited
in retinal neuronal cells including the ganglion cells, amacrine
cells, bipolar cells, horizontal cells, and photoreceptor cells
(Fig. 3B-D).
Discussion
This study confirms that caveolin-1 and -2 are expressed
in the eye, specifically in the retina, of rats. Based on the
functional role of caveolins, these molecules may be
assumed to play an important role in the cholesterol
homeostasis of the retina. An ultrastructural study has
shown that caveolin-1 is localized in the synaptic ribbons in
rod and cone photoreceptors of bovine retina, but not on
synaptic vesicles or in presynaptic plasma membranes [7].
Using light microscopy, we found that the two isoforms of
caveolin could be identified in the rat retina, and that
caveolin-1 was localized in a number of retinal cell layers.
Although some studies have described the presence of
caveolin-1 in the rod and cone layer in tissues examined by
transmission electron microscopy [2], here, little immunostaining
was found in that layer. In addition to the rod and cone layer,
caveolin-1 was diffusely immunostained in the ganglion cell
Fig. 2. Immunohistochemical labeling of caveolin-1 in the ra t
retina. Caveolin-1 was expressed in some glial cells (arrowheads),
vascular endothelial cells (arrows), and was diffusely stained i n
the inner plexiform layers, inner nuclear layer, outer plexiform
layer, and external limiting layer (A). Some ganglion cells were
immunopositive for caveolin-1 (C, arrows). In the inner nuclea r
layer, caveolin-1 was immunostained in some neuronal cells,
identical to amacrine cells (arrowhead) and bipolar cells (arrow)
in morphology and location (D). In the outer nuclear layer,
caveolin-1 was weakly detected in some photoreceptor cellula r
membranes (E, arrow), and inner segments of rods and cones (F,
arrow). No reaction product was seen in sections incubated wit h
non-immune sera (B). Counterstained with hematoxylin. The
retinal layers are indicated on the right side of the retinal sectio n
(B); ganglion cell layer (GCL), inner plexiform layer (IPL), inne r
nuclear layer (INL), outer plexiform layer (OPL), outer nuclea r
layer (ONL), layer of rods and cones (RCL). Scale bars: in A an d
B, 30 µm; in C-F, 10 µm.
Fig. 3. Immunohistochemical labeling of caveolin-2 in the ra t
retina. Caveolin-2 was typically immunostained in vessels of the
retina (arrow), while weak staining was seen in the processes o f
glial cells (arrowhead) (A). Caveolin-2 was diffusely stained i n
the inner plexiform layer (B). Caveolin-2-immunostaining was
found in the process of glial cells, identical Muller cells i n
morphology and location (C, arrow). Caveolin-2 was diffusely
immunostained in outer plexiform layer (D, arrowhead), bu t
limited in the inner and outer segments of rods and cones (D,
arrow). Counterstained with hematoxylin. The retinal layers are
indicated on the right side of the retinal section (A); ganglion cell
layer (GCL), inner plexiform layer (IPL), inner nuclear laye r
(INL), outer plexiform layer (OPL), outer nuclear layer (ONL),
layer of rods and cones (RCL). Scale bars: in A, 30 µm; in B-D,
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layer, inner plexiform layer, and inner nuclear layer, suggesting
that caveolin-1 has activity in these cell layers.
The present study has also confirmed that caveolin-2 is
typically localized in the majority of vessels in the retina,
and in a few process-bearing cells, but that the expression of
caveolin-2 is quite low compared with that of caveolin-1.
This finding suggests that the function of caveolin-2 may be
unique, although its sequence is similar to that of caveolin-1
[10,11].
In summary, we have found that all caveolins were
diffusely immunostained in the inner and outer plexiform
layers of rat retina. These layers contain a variety of
neuronal and glial cells, and have numerous synaptic
junctions. This finding, together with other evidence from
this and other studies, suggests that the caveolin-1 and -2,
individually or in combination, may be involved in synaptic
signal transduction in the retina. The determination of their
precise role in the retina will require further study.
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